Solubility evaluation of murine hybridoma antibodies

mAbs

Volumn 4, Issue 3, 2012, Pages 319-325

  Spencer, Stacey ^a   Bethea, Deidra ^a   Raju, T Shantha ^a   Giles Komar, Jill ^a   Feng, Yiqing ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Cross interaction chromatography; Glycosylation; Hybridoma; Immunoglobulin; Isoelectric point; Monoclonal antibody; Solubility

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CHROMATOGRAPHY; DRUG SOLUBILITY; GLYCOSYLATION; HYBRIDOMA; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MOUSE; NONHUMAN;

ANIMALS; ANTIBODIES, MONOCLONAL; HYBRIDOMAS; IMMUNOSORBENT TECHNIQUES; ISOELECTRIC FOCUSING; MICE; SOLUBILITY;

EID: 84860896925     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.19869     Document Type: Article

References (29)

1. Nieri P, Donadio E, Rossi S, Adinolfi B, PodestàA. Antibodies for therapeutic uses and the evolution of biotechniques. Curr Med Chem 2009; 16:753-79; PMID:19199935; http://dx.doi.org/10.2174/092986709787458380.
2. Dani B, Platz R, Tzannis ST. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration. J Pharm Sci 2007; 96:1504-17; PMID:17387698; http://dx.doi.org/10.1002/jps.20508.
3. Jespers L, Schon O, Famm K, Winter G. Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol 2004; 22:1161-5; PMID:15300256; http://dx.doi.org/10.1038/nbt1000.
4. Famm K, Winter G. Engineering aggregation-resistant proteins by directed evolution. Protein Eng Des Sel 2006; 19:479-81; PMID:16920746; http://dx.doi.org/10.1093/protein/gzl032.
5. Lienqueo ME, Mahn A, Navarro G, Salgado JC, Perez-Acle T, Rapaport I, et al. New approaches for predicting protein retention time in hydrophobic interaction chromatography. J Mol Recognit 2006; 19:260-9; PMID:16752432; http://dx.doi.org/10.1002/jmr.776.
6. Demeule B, Lawrence MJ, Drake AF, Gurny R, Arvinte T. Characterization of protein aggregation: the case of a therapeutic immunoglobulin. Biochim Biophys Acta 2007; 1774:146-53.
7. Harn N, Allan C, Oliver C, Middaugh CR. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. J Pharm Sci 2007; 96:532-46; PMID:17083094; http://dx.doi.org/10.1002/jps. 20753.
8. Trevino SR, Scholtz JM, Pace CN. Measuring and increasing protein solubility. J Pharm Sci 2008; 97:4155-66; PMID:18240286; http://dx.doi.org/10. 1002/jps.21327.
9. Tartaglia GG, Pawar AP, Campioni S, Dobson CM, Chiti F, Vendruscolo M. Prediction of aggregation-prone regions in structured proteins. J Mol Biol 2008; 380:425-36; PMID:18514226; http://dx.doi.org/10.1016/j.jmb.2008.05.013.
10. Jacobs SA, Wu SJ, Feng Y, Bethea D, O'Neil KT. Cross-interaction chromatography: a rapid method to identify highly soluble monoclonal antibody candidates. Pharm Res 2010; 27:65-71; PMID:19911257; http://dx.doi.org/10.1007/ s11095-009-0007-z.
11. Wu SJ, Luo J, O'Neil KT, Kang J, Lacy ER, Canziani G, et al. Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng Des Sel 2010; 23:643-51; PMID:20543007; http://dx.doi.org/10.1093/ protein/gzq037.
12. Pepinsky RB, Silvian L, Berkowitz SA, Farrington G, Lugovskoy A, Walus L, et al. Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci 2010; 19:954-66; PMID:20198683.
13. Marshall RD. The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem Soc Symp 1974; 40:17-26; PMID:4620382.
14. Bause E, Hettkamp H. Primary structural requirements for N-glycosylation of peptides in rat liver. FEBS Lett 1979; 108:341-4; PMID:520572; http://dx.doi.org/10.1016/0014-5793(79)80559-1.
15. Raju TS, Scallon BJ. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem Biophys Res Commun 2006; 341:797-803; PMID:16442075; http://dx.doi.org/10.1016/j.bbrc.2006.01.030.
16. Tanford C. Physical Chemistry of Macromolecules. New York: John Wiley 1961.
17. Agrawal NJ, Kumar S, Wang X, Helk B, Singh SK, Trout BL. Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. J Pharm Sci 2011; 100:5081-95; PMID:21789769; http://dx.doi.org/10.1002/jps.22705.
18. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 2007; 25:21-50; PMID:17029568; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141702.
19. Jefferis R, Lund J. Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett 2002; 82:57-65; PMID:12008035; http://dx.doi.org/ 10.1016/S0165-2478(02)00019-6.
20. Raju TS. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 2008; 20:471-8; PMID:18606225; http://dx.doi.org/10.1016/j.coi.2008.06.007.
21. Spiegelberg HL, Abel CA, Fishkin BG, Grey HM. Localization of the carbohydrate within the variable region of light and heavy chains of human gamma g myeloma proteins. Biochemistry 1970; 9:4217-23; PMID:5458650; http://dx.doi.org/10.1021/bi00823a025.
22. Wright A, Tao MH, Kabat EA, Morrison SL. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. EMBO J 1991; 10:2717-23; PMID:1717254.
23. Coloma MJ, Trinh RK, Martinez AR, Morrison SL. Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1→6) dextran antibody. J Immunol 1999; 162:2162-70; PMID:9973491.
24. Rudd PM, Wormald MR, Harvey DJ, Devasahayam M, McAlister MS, Brown MH, et al. Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor and immunoglobulin superfamilies expressed in Chinese hamster ovary cells. Glycobiology 1999; 9:443-58; PMID:10207177; http://dx.doi.org/10.1093/glycob/9.5.443.
25. Mayers GL, Bankert RB. Immunochemistry of monoclonal antibodies. Transplant Proc 1980; 12:413-6; PMID:6784300.
26. Tron F, Jacob L, Bach JF. Murine monoclonal anti-DNA antibodies with an absolute specificity for DNA have a large amount of idiotypic diversity. Proc Natl Acad Sci USA 1983; 80:6024-7; PMID:6193527; http://dx.doi.org/10.1073/pnas. 80.19.6024.
27. Daugherty AL, Mrsny RJ. Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev 2006; 58:686-706; PMID:16839640; http://dx.doi.org/10.1016/j.addr.2006.03.011.
28. Kozlowski S, Swann P. Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Deliv Rev 2006; 58:707-22; PMID:16828921; http://dx.doi.org/10.1016/j.addr.2006.05.002.
29. Tessier PM, Sandler SI, Lenhoff AM. Direct measurement of protein osmotic second virial cross coefficients by cross-interaction chromatography. Protein Sci 2004; 13:1379-90; PMID:15075404; http://dx.doi.org/10.1110/ps.03419204.